Abstract
Background: The main goals of total knee arthroplasty are pain relief and improvement of function and range of motion. To ascertain whether posterior cruciate-retaining-flex total knee prosthesis would improve pain, function and range of motion, we asked whether knee and pain scores, ranges of motion, WOMAC score, patient satisfaction, and radiographic results would be better in the knees with a high-flexion posterior cruciate-retaining prosthesis than in the knees with a standard posterior cruciate-retaining prosthesis.
Methods: Fifty-four patients (mean age, 69.7 years) received a standard posterior cruciate-retaining knee prosthesis in one knee and a high-flexion posterior cruciate-retaining knee prosthesis in the contralateral knee. Five patients were men, and forty-nine were women. The minimum follow-up was three years (mean 3.1 years). At each follow-up, the WOMAC score and range of knee motion were evaluated and patients were assessed clinically and radiographically with use of the knee-rating systems of the Knee Society and The Hospital for Special Surgery.
Results: The mean postoperative Knee Society and Hospital for Special Surgery knee scores were 93.7 and 89 points, respectively in the knees with a standard posterior cruciate-retaining prosthesis and those were 93.9 and 90 points, respectively in the knees with a high-flexion posterior cruciate-retaining prosthesis. The mean postoperative WOMAC score was 22 points. Postoperatively, the mean non-weight and weight bearing ranges of motion were 131° (range, 90° to 150°) and 115° (range, 75 to 145°), respectively in the knees with a standard prosthesis and those were 133° (range, 90° to 150°) and 118° (range, 75 to 145°), respectively in the knees with a highflexion prosthesis. Patients satisfaction and radiographic results were similar in both groups. No knee had aseptic loosening, revision, or osteolysis.
Conclusions: After a minimum follow-up of three years, we found no significant differences between the two groups with regard to range of knee motion or clinical and radiographic results.
Correspondence should be addressed to: EFORT Central Office, Technoparkstrasse 1, CH – 8005 Zürich, Switzerland. Email: office@efort.org